JAN JOHANNESSEN - 16 Feb 2022 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role
Director
Signature
/s/ William Solis, as Attorney-in-Fact for Jan Johannessen
Issuer symbol
TWST
Transactions as of
16 Feb 2022
Net transactions value
-$226,000
Form type
4
Filing time
18 Feb 2022, 15:35:20 UTC
Previous filing
10 Feb 2022
Next filing
09 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Options Exercise $70,000 +5,000 +97% $14.00 10,136 16 Feb 2022 Direct
transaction TWST Common Stock Sale $296,000 -5,000 -49% $59.20 5,136 16 Feb 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TWST Director Stock Option (right to buy) Options Exercise $0 -5,000 -18% $0.000000 22,304 16 Feb 2022 Common Stock 5,000 $14.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on February 17, 2021.
F2 1/3rd of the shares subject to the option vested and became exercisable on October 30, 2019, and 1/3rd of the shares subject to the option vest and become exercisable on each annual anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.